CSF1R and Leukoencephalopathy: Although microglial replacement by HSCT is far from perfect, allogeneic HSCT could be beneficial in patients with CSF1R-related leukoencephalopathy in clinical practice by providing brain-engrafting microglia-like cells with donor wild-type CSF1R to repopulate the microglial niche [2].